UK medical breath monitoring manufacturer Bedfont Scientific Ltd has agreed the acquisition of Logan Research Ltd in a deal to move the company into a new area of scientific applications for breath research.
Bedfont Scientific Ltd, established in 1976, research, development and manufacture a range of breath analysis monitors for medical applications, including smoking cessation, gastrointestinal disorders, inhaled nitric oxide therapy and asthma.
Image credit: Bedfont Scientific
Logan Research Ltd, established in 1994, are real pioneers in the development and manufacture of real-time trace gas analysis equipment, namely the well-known LR2000 and mass spectrometry for measuring airway inflammation in the medical area of asthma. This was the first clinical system for airway inflammation available and is still regarded as a ‘Gold Standard’ method today, cited in many clinical research papers worldwide.
Trevor Smith, MD of Bedfont Scientific Ltd said, “Having worked with Logan Research Ltd for many years now we value greatly their expertise and wealth of knowledge in the area of breath monitoring for scientific research applications. Bringing them into the Bedfont family is of great strategic importance to us, enabling us to further increase our rapid growth in this area and enter new research based activities, paving the way for future breath analysis developments.”
Ron Logan-Sinclair, MD of Logan Research Ltd said, “I look forward to our new relationship in becoming part of the Bedfont team and will work toward providing a vehicle in which to turn all their innovative and potentially lifesaving ideas and aspirations into a reality.”
Source: www.bedfont.com
Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board